title: [Indications for the use of magnesium in anesthesia and intensive care].
abstract: Magnesium (Mg), a cofactor in numerous enzymatic reactions, is often ignored by clinicians, as the symptomatology of Mg depletion is not specific and usually associated with that of the cause of the depletion. Furthermore, the plasma Mg concentration (0.8 to 1.1 mmol.L-1) is only equivalent to one percent of the total body content. A Mg deficit may exist while plasma Mg concentration is normal. Therefore other techniques for Mg assessment, such as the repletion test, as well as red blood cell and lymphocyte concentrations have been used. A renewed interest for Mg occurred as numerous studies have shown the therapeutic efficiency of Mg and as the mechanisms of its haemodynamic effects have been recognized. Mg regulates Na-K-ATPase activity, K channels activity and, most of all, it is a natural calcium channel blocking agent. These properties explain its important place in electrophysiology of myocardial cells and the effects on the tension of smooth muscles, resulting in a vasodilation and a bronchodilation respectively. The antagonistic effect of Mg on calcium decreases the presynaptic release of acetylcholine at the neuromuscular junction and the release of epinephrine at the peripheral sympathetic nerves and the adrenals. Mg potentiates the effect of non-depolarizing muscle relaxants. A Mg deficiency occurs often in ICU patients, in alcoholics and during use of diuretics. Simultaneous administration of Mg is often required for treatment of potassium deficiency. Mg has an anti-arrhythmic effect towards digoxin-mediated dysrhythmias and torsades de pointes, and can be efficient in other arrhythmias. Systematic use of Mg seems to decrease mortality of acute myocardial infarction and is justified during cardiac surgery, often associated with hypomagnesemia, because of vasodilation of coronary arteries and in order to prevent occurrence of arrhythmias. Mg, because of its calcium channel blocking properties and as it lowers the release of epinephrine, is indicated for surgery of pheochromocytoma. In eclamptic and pre-eclamptic patients, the use of Mg is valuable, but not as an anti-epileptic agent. Other clinical uses of Mg have been proposed, but they are either anecdotal or of uncertain efficiency.
authors.affiliation: Département d'Anesthésie-Réanimation, CHU, Angers.
authors.forename: A
authors.initials: A
authors.lastname: Delhumeau
authors.forename: J C
authors.initials: JC
authors.lastname: Granry
authors.forename: J P
authors.initials: JP
authors.lastname: Monrigal
authors.forename: F
authors.initials: F
authors.lastname: Costerousse
mesh_terms: D000758:Anesthesia; D002320:Cardiovascular Physiological Phenomena; D002490:Central Nervous System / Q000502:physiology; D003422:Critical Care; D006801:Humans; D008274:Magnesium / Q000097:blood / Q000502:physiology*; D015636:Magnesium Chloride / Q000627:therapeutic use; D008275:Magnesium Deficiency / Q000175:diagnosis / Q000209:etiology; D008278:Magnesium Sulfate / Q000627:therapeutic use; D009045:Motor Endplate / Q000502:physiology
chemical_list: D015636:Magnesium Chloride; D008278:Magnesium Sulfate; D008274:Magnesium
vernacular_title: Indications du magnésium en anesthésie-réanimation.